The Role of Spravato® in Mental Health: A New Option for Treatment-Resistant DepressionMental health conditions affect millions of people every year, yet not everyone experiences meaningful improvement with traditional antidepressant medications. For individuals living with treatment-resistant depression (TRD), finding relief can feel overwhelming after trying multiple medications without success. Fortunately, advancements in psychiatric medicine have introduced innovative therapies that provide new hope.

One of the most significant developments in recent years is Spravato® (esketamine), an FDA-approved prescription medication that offers a different approach to treating depression. Unlike conventional antidepressants that primarily target serotonin, norepinephrine, or dopamine, Spravato works through the brain’s glutamate system, helping restore neural connections associated with mood regulation.

At The Potter’s Behavioral Medicine Clinic, patients receive comprehensive psychiatric evaluations to determine whether Spravato therapy is an appropriate part of their personalized mental health treatment plan. The clinic is committed to providing evidence-based care that supports long-term emotional wellness and improved quality of life.

Understanding Spravato®

What Is Spravato?

Spravato is a prescription nasal spray containing esketamine, a derivative of ketamine. It is FDA-approved for adults with:

  • Treatment-resistant depression (TRD)
  • Major depressive disorder (MDD) with acute suicidal thoughts or behaviors (used in conjunction with comprehensive psychiatric care)

Spravato represents an entirely different class of antidepressant treatment. Rather than gradually altering neurotransmitter levels over several weeks, it works by affecting glutamate receptors, which play an essential role in learning, memory, and brain plasticity.

This unique mechanism allows many patients to experience symptom improvement much faster than with traditional oral antidepressants alone.

How Spravato Works in the Brain

A Different Biological Pathway

Traditional antidepressants primarily increase serotonin or norepinephrine availability within the brain. While effective for many individuals, these medications can take four to eight weeks before noticeable improvement occurs.

Spravato targets NMDA receptors, which influence glutamate activity. This process promotes:

  • Increased communication between brain cells
  • Enhanced synaptic plasticity
  • Repair of stress-related neural pathways
  • Improved emotional regulation
  • Restoration of healthier brain network function

Researchers believe this rapid enhancement of brain connectivity contributes to faster improvement in depressive symptoms.

Who May Benefit from Spravato?

Treatment-Resistant Depression

Treatment-resistant depression generally refers to depression that has not improved after trying at least two different antidepressant medications at adequate doses and durations.

Patients who may qualify often experience:

  • Persistent sadness
  • Loss of motivation
  • Fatigue
  • Difficulty concentrating
  • Feelings of hopelessness
  • Sleep disturbances
  • Reduced interest in previously enjoyable activities

For these individuals, Spravato offers an alternative treatment strategy when conventional medications have not provided sufficient relief.

Major Depressive Disorder with Acute Symptoms

Some individuals experiencing severe depressive episodes with suicidal thoughts may qualify for Spravato as part of a carefully supervised treatment program. The goal is to rapidly reduce depressive symptoms while ongoing psychiatric care addresses long-term recovery.

The Spravato Treatment Process

Initial Psychiatric Evaluation

Every patient begins with a comprehensive psychiatric assessment that reviews:

  • Mental health history
  • Previous medication trials
  • Current symptoms
  • Medical history
  • Current medications
  • Treatment goals

This evaluation helps determine whether Spravato is appropriate and safe.

In-Office Administration

Spravato is never taken at home. Because of its potential side effects, the medication must be administered in a certified healthcare setting under medical supervision.

During each visit:

  • The patient self-administers the nasal spray under provider guidance.
  • Blood pressure and overall health are monitored.
  • Patients remain in the office for observation for approximately two hours.
  • Medical staff monitor for side effects before discharge.

Patients must arrange transportation home because driving is not permitted after treatment.

Treatment Schedule

Induction Phase

Most patients begin with:

  • Two treatments per week for four weeks

Maintenance Phase

After the initial phase, treatment frequency often decreases to:

  • Once weekly
  • Every other week
  • Individualized maintenance based on clinical response

The schedule is customized according to each patient’s progress and ongoing psychiatric evaluation.

Benefits of Spravato Therapy

Faster Symptom Relief

One of Spravato’s most significant advantages is the potential for relatively rapid improvement compared to traditional antidepressants.

Many patients notice:

  • Improved mood
  • Reduced hopelessness
  • Better emotional stability
  • Increased motivation
  • Improved concentration
  • Better daily functioning

Although individual responses vary, many patients experience meaningful improvement sooner than expected with standard medication alone.

Comprehensive Care

Spravato is not a stand-alone cure. Instead, it works best as part of a comprehensive treatment plan that may include:

  • Medication management
  • Individual therapy
  • Cognitive behavioral therapy (CBT)
  • Lifestyle interventions
  • Family support
  • Stress management
  • Ongoing psychiatric follow-up

This integrated approach supports sustainable recovery.

Safety and Monitoring

Why Monitoring Matters

Spravato can temporarily cause:

  • Increased blood pressure
  • Dizziness
  • Drowsiness
  • Dissociation
  • Nausea
  • Mild sedation

Because of these effects, every treatment session includes medical monitoring before patients leave the clinic.

This structured approach helps maximize safety while ensuring appropriate response to any temporary side effects.

Is Spravato Addictive?

Understanding the Difference

Patients often ask whether Spravato is addictive because it is chemically related to ketamine.

Spravato is administered under strict federal safety guidelines through the Risk Evaluation and Mitigation Strategy (REMS) program. Because treatment occurs only in certified medical facilities with professional supervision, the risk of misuse is significantly reduced.

Patients never take Spravato home, and each treatment follows standardized monitoring protocols.

Spravato Compared to Traditional Antidepressants

Key Differences

Traditional antidepressants:

  • Primarily target serotonin or norepinephrine
  • Often require several weeks for improvement
  • Are typically taken daily at home

Spravato:

  • Targets glutamate pathways
  • May provide faster symptom improvement
  • Is administered only in certified medical offices
  • Includes mandatory observation after treatment

Rather than replacing all antidepressants, Spravato is frequently used alongside oral antidepressant medications for eligible patients.

The Importance of Personalized Mental Health Care

Every Depression Journey Is Different

Depression affects each individual differently. Some people respond well to their first medication, while others require several treatment approaches before achieving meaningful improvement.

At The Potter’s Behavioral Medicine Clinic, psychiatric providers develop individualized treatment plans based on:

  • Symptom severity
  • Previous treatment history
  • Medical conditions
  • Lifestyle factors
  • Personal goals
  • Ongoing progress

This personalized approach helps patients receive care tailored to their unique needs.

Hope for Individuals Living with Treatment-Resistant Depression

Living with persistent depression can affect every aspect of daily life, including relationships, work performance, physical health, and overall well-being. When traditional treatments have not provided adequate relief, innovative therapies like Spravato offer another evidence-based option worth discussing with a qualified psychiatric provider.

The Potter’s Behavioral Medicine Clinic provides compassionate, comprehensive psychiatric care while helping patients explore advanced treatment options that support lasting recovery. With individualized evaluations, careful monitoring, and a commitment to evidence-based medicine, the clinic helps patients take meaningful steps toward improved mental health and a brighter future.

Frequently Asked Questions

What is Spravato used to treat?

Spravato is FDA-approved for adults with treatment-resistant depression and for certain adults with major depressive disorder experiencing acute suicidal thoughts or behaviors when used alongside comprehensive psychiatric care.

How is Spravato different from ketamine?

Spravato contains esketamine, a specific form of ketamine that has undergone FDA approval for certain psychiatric conditions. It is administered under strict medical supervision through certified treatment centers.

How quickly does Spravato work?

Some patients notice symptom improvement within hours or days, although response times vary. Others experience gradual improvement over several weeks as treatment continues.

Can I drive after a Spravato treatment?

No. Patients should not drive or operate machinery until the following day after a restful night’s sleep. Transportation home must be arranged before each appointment.

Do I continue taking my regular antidepressant?

In many cases, yes. Spravato is commonly prescribed alongside an oral antidepressant as part of a comprehensive treatment plan.

Is Spravato covered by insurance?

Many insurance plans provide coverage for eligible patients, although benefits vary. The clinic can help verify coverage and discuss treatment options.

What happens during a Spravato appointment?

Patients self-administer the nasal spray under medical supervision, remain at the clinic for approximately two hours of monitoring, and are discharged once providers determine it is safe to leave.

Who qualifies for Spravato?

Eligibility depends on several factors, including diagnosis, treatment history, overall health, and psychiatric evaluation. A provider at The Potter’s Behavioral Medicine Clinic can determine whether Spravato is appropriate.

Are side effects permanent?

Most side effects are temporary and resolve during the observation period. Medical staff carefully monitor patients throughout every treatment session.

Can Spravato cure depression?

Spravato is not considered a cure. It is one component of a comprehensive treatment plan designed to reduce symptoms, improve functioning, and support long-term mental health.

Contact Information

The Potter’s Behavioral Medicine Clinic

Website: https://thepottersclinic.com

Villa Rica

307 Old Stone Road
Villa Rica, GA 30180

Phone: (770) 459-8799

Hiram

5604 Wendy Bagwell Pkwy
Hiram, GA 30141

Phone: (770) 439-3070

Stockbridge – Virtual Visits

255 Corporate Centre Drive
Stockbridge, GA 30281

Phone: (770) 459-8799

Decatur – Virtual Visits

5322 Snapfinger Park Drive
Decatur, GA 30035

Phone: (770) 459-8799

Villa Rica Hiram Stockbridge - Virtual Visits Decatur
Virtual Visits
Appointments

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset